文献速递慢性肾脏病肾小球疾病

人工智能工具预测IgA肾病终末期肾病的开发与测试

Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.
PubMed 文献 · Kidney Int · 2020-09-02

基于948例原发性IgA肾病患者的回顾性队列,开发人工神经网络预测模型,采用两步法(分类器预测ESKD,回归模型预测ESKD发生时间)。回归模型平均绝对误差1.78年,均方根误差2.15年。

要点

  • 独立验证队列中91%患者预测成功,校准良好,判别能力优于其他模型。
  • 动态判别指数(1年和2年时间依赖AUC加权平均)分别为0.80和0.79,25年随访结果相似。

核心结论

  • 人工神经网络工具能识别IgA肾病中ESKD高风险个体并预测事件发生时间。

研究设计与样本

  • 回顾性队列研究,使用948例原发性IgA肾病患者开发模型,并在167例独立队列中验证。
  • 模型为两步法:分类器模型预测ESKD,回归模型预测ESKD发生时间。

主要发现

  • 回归模型平均绝对误差1.78年,均方根误差2.15年。
  • 独立队列中91%患者预测成功。
  • 动态判别指数(1年和2年时间依赖AUC加权平均)分别为0.80和0.79,25年随访结果相似。

临床怎么用

  • 该工具可辅助识别IgA肾病中高ESKD风险患者,预测发生时间,为治疗策略提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have developed an artificial neural network prediction model for end-stage kidney disease (ESKD) in patients with primary immunoglobulin A nephropathy (IgAN) using a retrospective cohort of 948 patients with IgAN. Our tool is based on a two-step procedure of a classifier model that predicts ESKD, and a regression model that predicts development of ESKD over time. The classifier model showed a performance value of 0.82 (area under the receiver operating characteristic curve) in patients with a follow-up of five years, which improved to 0.89 at the ten-year follow-up. Both models had a higher recall rate, which indicated the practicality of the tool. The regression model showed a mean absolute error of 1.78 years and a root mean square error of 2.15 years. Testing in an independent cohort of 167patients with IgAN found successful results for 91% of the patients. Comparison of our system with other mathematical models showed the highest discriminant Harrell C index at five- and ten-years follow-up (81% and 86%, respectively), paralleling the lowest Akaike information criterion values (355.01 and 269.56, respectively). Moreover, our system was the best calibrated model indicating that the predicted and observed outcome probabilities did not significantly differ. Finally, the dynamic discrimination indexes of our artificial neural network, expressed as the weighted average of time-dependent areas under the curve calculated at one and two years, were 0.80 and 0.79, respectively. Similar results were observed over a 25-year follow-up period. Thus, our tool identified individuals who were at a high risk of developing ESKD due to IgAN and predicted the time-to-event endpoint. Accurate prediction is an important step toward introduction of a therapeutic strategy for improving clinical outcomes.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Schena FP, Anelli VW, Trotta J, et al. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy. Kidney Int. 2020. PMID: 32889014. doi:10.1016/j.kint.2020.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。